vepsitamab (AMG 199) / Amgen, BeiGene  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
vepsitamab (AMG 199) / Amgen
NCT04117958: Study of AMG 199 in Subjects With MUC17-Positive Solid Tumors Including Gastric, Gastroesophageal Junction, Colorectal, and Pancreatic Cancers

Terminated
1
58
Europe, Japan, US, RoW
AMG 199
Amgen
MUC17-positive Solid Tumors
06/23
06/23

Download Options